A Forrester Consulting study, commissioned by TransPerfect but conducted independently, found that TransPerfect’s GlobalLink® technology suite delivered a net present value of $2.55 million for a global pharmaceutical company by improving translation workflows. The company overcame inefficiencies caused by fragmented, decentralized translation processes by integrating GlobalLink with its existing systems, resulting in better governance, reduced costs, and higher translation quality. The study highlighted enhanced transparency, oversight, and streamlined operations as key benefits, reinforcing GlobalLink’s value in supporting global clinical and regulatory activities.